APPLIED GENETIC TECHNOL CORP's ticker is AGTC and the CUSIP is 03820J100. A total of 73 filers reported holding APPLIED GENETIC TECHNOL CORP in Q2 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $328,000 | +111.6% | 64,622 | +70.2% | 0.00% | – |
| Q4 2020 | $155,000 | -10.9% | 37,969 | +5.8% | 0.00% | – |
| Q3 2020 | $174,000 | -10.8% | 35,881 | +1.9% | 0.00% | – |
| Q2 2020 | $195,000 | +10.8% | 35,200 | +37.9% | 0.00% | – |
| Q1 2017 | $176,000 | -27.9% | 25,519 | -2.3% | 0.00% | – |
| Q4 2016 | $244,000 | -7.2% | 26,119 | -3.0% | 0.00% | -100.0% |
| Q3 2016 | $263,000 | -30.1% | 26,919 | +1.1% | 0.00% | 0.0% |
| Q2 2016 | $376,000 | +41.9% | 26,619 | +40.6% | 0.00% | 0.0% |
| Q1 2016 | $265,000 | -20.4% | 18,935 | +16.0% | 0.00% | 0.0% |
| Q4 2015 | $333,000 | +58.6% | 16,321 | +2.2% | 0.00% | 0.0% |
| Q3 2015 | $210,000 | -14.6% | 15,963 | -0.6% | 0.00% | 0.0% |
| Q2 2015 | $246,000 | +18.3% | 16,063 | +54.5% | 0.00% | – |
| Q1 2015 | $208,000 | -5.0% | 10,396 | 0.0% | 0.00% | -100.0% |
| Q4 2014 | $219,000 | +13.5% | 10,396 | +0.4% | 0.00% | – |
| Q3 2014 | $193,000 | -6.3% | 10,351 | +16.3% | 0.00% | -100.0% |
| Q2 2014 | $206,000 | – | 8,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 167,192 | $2,362,000 | 1.87% |
| Perceptive Advisors | 658,851 | $9,309,000 | 0.64% |
| Iguana Healthcare Management, LLC | 100,000 | $1,413,000 | 0.58% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 416,498 | $5,885,000 | 0.33% |
| TFS CAPITAL LLC | 111,937 | $1,582,000 | 0.29% |
| GLOBEFLEX CAPITAL L P | 70,554 | $997,000 | 0.27% |
| Eventide Asset Management | 279,100 | $3,944,000 | 0.24% |
| EMERALD ADVISERS, LLC | 290,784 | $4,109,000 | 0.20% |
| Spark Investment Management LLC | 133,600 | $1,887,000 | 0.18% |
| Virtus ETF Advisers LLC | 16,223 | $229,000 | 0.17% |